Recently, Shanghai United Imaging Intelligence Medical Technology Co., Ltd. (hereinafter "United Imaging Intelligence") announced the completion of its Series A financing (hereinafter "this round of financing"). The total financing amount reached RMB 1 billion, jointly led by E Fund Private Equity Management Co., Ltd. and SDIC Capital Holdings Co., Ltd., with participation from Shanghai Alliance Investment, Sunrock Capital, Baolan Investment, Suzhou Capital Group, Junwei Venture, Tsing Song Capital, Zhangjiagang Capital, United Imaging Group, United Imaging Healthcare, and other institutions.
Message from the Entrepreneur:
"This milestone achievement not only confirms United Imaging Intelligence's leading strength in the medical AI field but also reflects the industry's high recognition and confidence in our development… We sincerely appreciate China International Capital Corporation for their professional guidance during the financing process, Llinks Law Offices for their expert legal consultation, our new and existing shareholders for their trust, and all United Imaging Intelligence employees for their dedication!"
As a company focused on medical artificial intelligence, United Imaging Intelligence has been dedicated since its establishment to deeply integrating advanced AI technologies into multiple key areas including medical imaging analysis, intelligent diagnostic assistance, medical data management, disease prediction, high-end medical device innovation, and clinical research. It provides multi-scenario, multi-disease, full-process, integrated intelligent solutions for the healthcare industry. After years of intensive development, United Imaging Intelligence has successfully launched over 100 medical AI products, dozens of which have obtained Class III and Class II NMPA certificates, FDA approval in the United States, and CE certification in the European Union, gaining wide recognition in both domestic and international markets.
The successful completion of this Series A financing will accelerate United Imaging Intelligence's dual-track advancement in technological innovation and product implementation. On the technology front, the company will further increase R&D investment in cutting-edge areas such as medical large models and intelligent agents, accelerating deep innovation and application expansion of AI in healthcare to elevate the level of medical intelligence to a new stage. On the product front, United Imaging Intelligence will continue to optimize its product service system, speed up market expansion, and promote clinical translation and implementation of technological innovations, enabling more medical institutions and patients to benefit from leading medical AI solutions.
As legal counsel to United Imaging Intelligence, Llinks fully leveraged its integrated platform advantages and rich project experience in investment and financing to provide comprehensive legal support throughout this round of financing.
Llinks Engagement Team:
Baker Chen, Partner
Fiona Zhu, Contractual Partner
